AUSTIN, Texas -- Texas' health services department is warning that five of its regional infusion centers have run out of the only monoclonal antibody treatment known to be effective against the ...

Please provide your email address to receive an email when new articles are posted on . A 500 mg intramuscular injection of sotrovimab was noninferior to an IV infusion of the investigational ...

Administering the monoclonal antibody sotrovimab intramuscularly was noninferior to the intravenous (IV) route for high-risk COVID patients, a researcher said. The risk difference between groups for ...

SEMINOLE COUNTY, Fla. — After the FDA’s decision to remove authorization for Regeneron’s use, an antibody infusion treatment center in Seminole County was able to continue treating patients with an ...

SAN FRANCISCO, March 25, 2022 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the US Food and Drug Administration has amended the ...

PEORIA – Monoclonal antibodies, which continue to be an effective way to reduce the severity of COVID-19 infection, have evolved over the course of the pandemic. Just this week, the Food and Drug ...

BEAUMONT, Texas — Southeast Texas health professionals are working hard to keep people out of the hospitals during the current COVID-19 surge. The Southeast Texas Infusion Center has seen a recent ...

New Jersey hospitals have tightened access to COVID-19 monoclonal antibody treatments after the two previously leading therapies failed to work against the omicron variant and a newer, more effective ...

BEAUMONT, Texas — The Southeast Texas Regional Infusion center is closed Wednesday after running out of Sotrovimab, a monoclonal antibody used to treat COVID-19. (EDITOR'S NOTE: The video above is ...

Due to new direction from the Centers for Disease Control and Prevention and the Texas Department of State Health Services, the Amarillo Area Infusion Center began providing Sotrovimab for COVID-19 ...

Five of the department’s regional infusion centers have run out of sotrovimab, the only antibody treatment known to be effective against the new variant. Isidro Bernardino receives a COVID-19 antibody ...

Texas' health services department is warning that five of its regional infusion centers have run out of the only monoclonal antibody treatment known to be effective against the omicron variant of ...